Arda Therapeutics Secures $43M Series A Financing to Advance Targeted Cell Depletion Therapies Read more
Biogen Secures FDA Breakthrough Therapy Designation for Felzartamab to Combat Antibody-Mediated Rejection in Kidney Transplants Read more
insitro and Lilly Enter Strategic Agreements to Advance Novel Treatments for Metabolic Diseases Read more
Boehringer receives FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide Read more
Innovent and Ask Pharm Announce Strategic Collaboration for Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer Read more
Teva and mAbxience Strengthen Strategic Alliance with New Oncology Biosimilar Candidate Addition Read more
Resilience Secures Funding to Expand Domestic Manufacturing for Critical Pharmaceutical Ingredients Read more
FDA Approves Neoadjuvant Opdivo and Chemotherapy for Resectable Non-Small Cell Lung Cancer Treatment Pathway Read more